Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostat...

por Vargas, Carlos E., Schmidt, Matthew Q., Niska, Joshua R., Hartsell, William F., Keole, Sameer R., Doh, Lucius, Chang, John Han-Chih, Sinesi, Christopher, Rodriquez, Rossio, Pankuch, Mark, Larson, Gary L.
Publicado 2018